CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies
NCT ID: NCT05127837
Last Updated: 2025-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
379 participants
INTERVENTIONAL
2022-06-28
2024-12-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI-Based Fidelity Feedback to Enhance CBT
NCT05340738
Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study
NCT06831435
Can Computational Measures of Task Performance Predict Psychiatric Symptoms and Changes in Symptom Severity Across Time
NCT06705179
RCT of Psilocybin-assisted CBT for Depression
NCT07281352
Game-based Telehealth Therapeutic Intervention in First Onset Psychosis
NCT04799717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Once technical reliability of the tool is achieved through iterative modifications based on usability and field trials, a randomized control trial will be conducted to assess CBTpro training vs. training as usual with N=100 providers / N=300 clients on clinician skills and client outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment as Usual (TAU)
CBT for psychosis distance learning course.
No interventions assigned to this group
CBTpro
In addition to TAU, clinicians and clients receive the CBTpro training.
CBTpro
CBTpro is a novel spoken language technology tool to support high-quality skills training in CBT for psychosis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBTpro
CBTpro is a novel spoken language technology tool to support high-quality skills training in CBT for psychosis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion criteria: Dx of psychosis secondary to substance intoxication
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Lyssn.io, Inc.
INDUSTRY
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Kopelovich
Associate Professor of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Kopelovich, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
South Central Health and Rehabilitation Programs
Los Angeles, California, United States
Psynergy
Morgan Hill, California, United States
Telecare
San Jose, California, United States
Integrated Services of Kalamazoo
Kalamazoo, Michigan, United States
Community Mental Health Authority of Clinton, Eaton, and Ingham Counties (CEICMH)
Lansing, Michigan, United States
Coleman Health Services
Akron, Ohio, United States
PeaceHealth
Eugene, Oregon, United States
Cascadia
Portland, Oregon, United States
Lifeworks NW
Portland, Oregon, United States
Harborview Medical Center
Seattle, Washington, United States
Sound Health
Seattle, Washington, United States
Frontier Behavioral Health
Spokane, Washington, United States
Comprehensive Healthcare
Yakima, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00014706
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.